These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4918177)

  • 1. [Phage control of the synthesis of group-specific antigen 7,8 in Shigella flexneri].
    Petrovskaia VG; Bondarenko VM
    Vestn Akad Med Nauk SSSR; 1969; 24(12):52-6. PubMed ID: 4918177
    [No Abstract]   [Full Text] [Related]  

  • 2. Trials of transduction with defective Shigella flexneri phage.
    Bohdanowicz-Murek K
    Arch Immunol Ther Exp (Warsz); 1971; 19(3):327-42. PubMed ID: 4938011
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of genetic control of synthesis of the typospecificity in Shigella antigens of the subgroup B].
    Timakov VD; Petrovkaia VG; Bondarenko VM; Lycheva TA
    Vestn Akad Med Nauk SSSR; 1969; 24(11):48-58. PubMed ID: 4098562
    [No Abstract]   [Full Text] [Related]  

  • 4. Sh. dysenteriae serotypes2,4,8-immunochemistry and phage receptor activity.
    Goldhar J; Barber C; Eylan E
    Zentralbl Bakteriol Orig A; 1976 Oct; 236(1):89-98. PubMed ID: 63197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysogeny and lysosensitivity in Shigella dysenteriae group of bacteria. I. Isolation of bacteriophages and receptor substances.
    Goldhar J; Eylan E; Goldschmied-Reouven A
    Med Microbiol Immunol; 1973 Sep; 159(1):63-72. PubMed ID: 4588887
    [No Abstract]   [Full Text] [Related]  

  • 6. Construction and characterization of genetically-marked bivalent anti-Shigella dysenteriae 1 and anti-Shigella flexneri Y live vaccine candidates.
    Klee SR; Tzschaschel BD; Singh M; Fält I; Lindberg AA; Timmis KN; Guzmán CA
    Microb Pathog; 1997 Jun; 22(6):363-76. PubMed ID: 9188091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of quantitative content of complete antigen in Shigella dysenteriae cultures in lytic activity of bacteriophage].
    PEREMITINA LD
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Jul; 28(7):56-61. PubMed ID: 13497215
    [No Abstract]   [Full Text] [Related]  

  • 8. Serologic analysis of the lac + hybrid of Escherichia coli K-12 HFRC and variant Y of Shigella flexneri.
    Kolodynski J
    Arch Immunol Ther Exp (Warsz); 1971; 19(6):743-8. PubMed ID: 4946992
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the genetic control of shigella sub-group B type specific antigens. I. Behaviour of Shigella flexneri type specific antigens in sexual recombination of Shigella x E. coli.
    Timakov VD; Petrovskaya VG; Bondarenko VM
    Ann Inst Pasteur (Paris); 1970 Jan; 118(1):3-9. PubMed ID: 4906593
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic crosses between restricted and unrestricted phage T1 in lysogenic and non-lysogenic hosts.
    DREXLER H; CHRISTENSEN JR
    Virology; 1961 Jan; 13():31-9. PubMed ID: 13724384
    [No Abstract]   [Full Text] [Related]  

  • 11. Lysogenic conversion in the Shigella flexneri group.
    Kétyi I; Vertényi A; Financsek I
    Acta Microbiol Acad Sci Hung; 1971; 18(1):47-54. PubMed ID: 4947098
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of transmission factors in the preservation of the autonomic genetic determinants of resistance to antibiotics].
    Astapov AA
    Antibiotiki; 1971 Oct; 16(10):899-900. PubMed ID: 4945038
    [No Abstract]   [Full Text] [Related]  

  • 13. Construction of recombinant aroA salmonellae stably producing the Shigella dysenteriae serotype 1 O-antigen and structural characterization of the Salmonella/Shigella hybrid LPS.
    Fält IC; Mills D; Schweda EK; Timmis KN; Lindberg AA
    Microb Pathog; 1996 Jan; 20(1):11-30. PubMed ID: 8692007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope mapping of six monoclonal antibodies recognizing the Shigella dysenteriae type 1 O-antigenic repeating unit expressed in Escherichia coli K-12.
    Fält IC; Lindberg AA
    Microb Pathog; 1994 Jan; 16(1):27-41. PubMed ID: 7520112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Properties of individual mononucleotides of DNA of phage DDVII (Shigella dysenteriae flexneri)].
    Trushinskaia GN; Nikol'skaia II; Tikhonenko TI
    Vopr Virusol; 1972; 17(1):107-12. PubMed ID: 4552118
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lysogenic conversion of antigenic characteristics of Shigella (type II antigens and Group 7,8 complex)].
    Giammanco G
    Ann Inst Pasteur (Paris); 1968 Jan; 114(1):63-76. PubMed ID: 5650310
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation of a rough somatic antigen from Shigella dysenteriae.
    DAVIES DA
    Biochim Biophys Acta; 1957 Oct; 26(1):151-8. PubMed ID: 13479473
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk areas and neighborhood-level risk factors for Shigella dysenteriae 1 and Shigella flexneri.
    Emch M; Ali M; Yunus M
    Health Place; 2008 Mar; 14(1):96-105. PubMed ID: 17602851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage-dependent changes in Shigella flexneri type antigen synthesis.
    Financsek I; Ketyi I; Sasak W; Jankowski W; Janczura E; Chojnacki T
    Infect Immun; 1976 Dec; 14(6):1290-2. PubMed ID: 793990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On lactosepositive variants of Sh. flexneri 2a and serotype 145-46.
    Trifonova A; Tekelieva R
    Zentralbl Bakteriol Orig; 1969 Jan; 209(2):196-203. PubMed ID: 5386532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.